Correlation Between Edgewise Therapeutics and TransMedics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and TransMedics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and TransMedics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and TransMedics Group, you can compare the effects of market volatilities on Edgewise Therapeutics and TransMedics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of TransMedics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and TransMedics.

Diversification Opportunities for Edgewise Therapeutics and TransMedics

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Edgewise and TransMedics is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and TransMedics Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TransMedics Group and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with TransMedics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TransMedics Group has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and TransMedics go up and down completely randomly.

Pair Corralation between Edgewise Therapeutics and TransMedics

Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the TransMedics. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.66 times less risky than TransMedics. The stock trades about -0.06 of its potential returns per unit of risk. The TransMedics Group is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  8,192  in TransMedics Group on August 31, 2024 and sell it today you would earn a total of  519.00  from holding TransMedics Group or generate 6.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Edgewise Therapeutics  vs.  TransMedics Group

 Performance 
       Timeline  
Edgewise Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Edgewise Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Edgewise Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
TransMedics Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TransMedics Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Edgewise Therapeutics and TransMedics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Edgewise Therapeutics and TransMedics

The main advantage of trading using opposite Edgewise Therapeutics and TransMedics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, TransMedics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TransMedics will offset losses from the drop in TransMedics' long position.
The idea behind Edgewise Therapeutics and TransMedics Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stocks Directory
Find actively traded stocks across global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine